sr141716 has been researched along with n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, Z; Rawls, SM; Rodriguez, T; Schroeder, JA; Zaveri, N | 1 |
| Corley, G; Rawls, SM | 1 |
2 other study(ies) available for sr141716 and n-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide
| Article | Year |
|---|---|
NOP receptor antagonist, JTC-801, blocks cannabinoid-evoked hypothermia in rats.
Topics: Aminoquinolines; Analgesics; Animals; Benzamides; Benzoxazines; Body Temperature; Cannabinoids; Humans; Hypothermia; Male; Morpholines; Naphthalenes; Narcotic Antagonists; Nociceptin Receptor; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid; Rimonabant | 2007 |
Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats.
Topics: Acetaminophen; Aminoquinolines; Animals; Benzamides; Body Temperature; Hypothermia, Induced; Male; Naltrexone; Nociceptin Receptor; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Opioid; Rimonabant | 2009 |